KIAA1586 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.810400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.091200E-01
Normal-vs-Stage2
2.552100E-02
Normal-vs-Stage3
2.973600E-02
Normal-vs-Stage4
2.424800E-01
Stage1-vs-Stage2
2.841000E-01
Stage1-vs-Stage3
2.794600E-01
Stage1-vs-Stage4
9.458800E-01
Stage2-vs-Stage3
5.914400E-01
Stage2-vs-Stage4
3.261600E-01
Stage3-vs-Stage4
1.079550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.916400E-02
Normal-vs-AfricanAmerican
2.199200E-01
Normal-vs-Asian
3.616200E-03
Caucasian-vs-AfricanAmerican
5.578000E-01
Caucasian-vs-Asian
1.167190E-01
AfricanAmerican-vs-Asian
9.837900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.414000E-02
Normal-vs-Female
5.238400E-02
Male-vs-Female
1.836620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.729040E-01
Normal-vs-Age(41-60Yrs)
1.298550E-01
Normal-vs-Age(61-80Yrs)
2.139800E-02
Normal-vs-Age(81-100Yrs)
3.605900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.452800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.723000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.592200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.046300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.680600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.854000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.419880E-02
Normal-vs-Daily Drinker
2.408400E-04
Normal-vs-Weekly Drinker
4.120000E-03
Normal-vs-Occasional Drinker
1.268230E-01
Normal-vs-Social Drinker
3.591600E-01
Non Drinker-vs-Daily Drinker
5.547900E-02
Non Drinker-vs-Weekly Drinker
9.115800E-01
Non Drinker-vs-Occasional Drinker
2.902200E-01
Non Drinker-vs-Social Drinker
3.282000E-01
Daily Drinker-vs-Weekly Drinker
6.898000E-02
Daily Drinker-vs-Occasional Drinker
1.740460E-02
Daily Drinker-vs-Social Drinker
6.107800E-02
Weekly Drinker-vs-Occasional Drinker
2.762800E-01
Weekly Drinker-vs-Social Drinker
2.995200E-01
Occasional Drinker-vs-Social Drinker
7.645400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.360600E-01
Normal-vs-Grade 2
4.181000E-01
Normal-vs-Grade 3
4.444200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.137200E-01
Grade 1-vs-Grade 3
5.677800E-01
Grade 1-vs-Grade 4
3.360600E-01
Grade 2-vs-Grade 3
9.993400E-01
Grade 2-vs-Grade 4
4.181000E-01
Grade 3-vs-Grade 4
4.444200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.201800E-02
Normal-vs-NonDiabetic
2.037900E-02
Diabetic-vs-NonDiabetic
9.762000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.295150E-03
Normal-vs-NoPancreatitis
3.013800E-02
Pancreatitis-vs-NoPancreatitis
8.535500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.802200E-02
Normal-vs-N1
3.144300E-02
N0-vs-N1
5.810000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.061700E-02
Normal-vs-TP53-NonMutant
2.191800E-01
TP53-Mutant-vs-TP53-NonMutant
1.041790E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
